Thesis
Immunisation of children and adolescents against COVID-19: immunogenicity and reactogenicity of heterologous and fractional dose schedules
- Abstract:
-
COVID-19 vaccination has been shown to protect children and adolescents against SARS-CoV-2 infection and disease, with efficacy increasing with additional doses. However, the increased risk of myocarditis associated with mRNA vaccination in adolescents, particularly following a seconddose, suggests a potential role for fractional or heterologous second doses. Data regarding heterologous and fractional dose COVID-19 vaccine schedules in adolescents, however, are lacking. Additionally, the decl...
Expand abstract
Actions
Access Document
- Files:
-
-
(Preview, Dissemination version, pdf, 23.8MB, Terms of use)
-
Authors
Contributors
+ Bibi, S
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Paediatrics
- Role:
- Supervisor
- ORCID:
- 0000-0002-0855-2737
+ Clutterbuck, E
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Paediatrics
- Role:
- Supervisor
- ORCID:
- 0000-0003-1701-1390
+ Kelly, D
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Paediatrics
- Role:
- Supervisor
- ORCID:
- 0000-0002-6063-8896
+ Liu, X
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Paediatrics
- Role:
- Supervisor
+ Minassian, A
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- Paediatrics
- Role:
- Supervisor
+ European Society for Paediatric Infectious Diseases
More from this funder
- Funder identifier:
- https://ror.org/00jvfh371
- DOI:
- Type of award:
- DPhil
- Level of award:
- Doctoral
- Awarding institution:
- University of Oxford
- Language:
-
English
- Pubs id:
-
2407709
- Local pid:
-
pubs:2407709
- Deposit date:
-
2026-03-25
- ARK identifier:
Terms of use
- Copyright holder:
- Eimear Kelly
- Copyright date:
- 2025
If you are the owner of this record, you can report an update to it here: Report update to this record